|
|
|
Digg It!
|
Rating: 0.0/5 (0 votes cast)
|
|
|
| JIM BECK and MARK HERRMANN's personal views of various topics that arise in the defense of pharmaceutical and medical device product liability litigation. |
|
|
Blog Details |
Overall rank: 70960 Number of inbound blogs: 95 Number of incoming links: 315 ATOM: ATOM feed Last update: 2008-03-31 12:36:32 GMT Estimated value: $213,434 |
|
Analytics |
Incoming clicks since last reset: 0 Outgoing clicks since last reset: 0 |
|
Latest Posts |
Lanier on Torts at HarvardPseudoephedrine Nuisance Claims RejectedJudicial WisdomSprint Fidelis Preemption Decision - YessssssOy, Canada!Happy New Year on the Class Action FrontTop Ten Best And Worst Prescription Drug/Medical Device Decisions of 2008 - The BestRegulatory Preemption - Class II Devices and Special ControlsPolar Bears Nudge the MDL Panel In A Helpful DirectionSupreme Court Conference 1/9/09Off-Label Promotion MDL Dismissed under FDCATop Ten Best And Worst Prescription Drug/Medical Device Decisions of 2008 - The WorstA Gripe With A Piece of Scientific LiteraturePreemption and Investigational Devices after RiegelBong Water BluesInformal Physician Interviews - Where It's Kosher; Where It's NotGunvalson v. PTC Therapeutics: Injunction ReversedNew York, New York (reprise)Amending FAS 5 -- An UpdateBlog HonorsOn Communicating By E-MailWhat Does Good Say For Levine?Altria v. Good DecidedA Look At Some Recent ScholarshipDoJ/FDA Take Positions On §337(a), “Parallel” Requirements Litigation
|
|